UBS lowered the firm’s price target on Nutanix (NTNX) to $57 from $91 and keeps a Buy rating on the shares after assuming coverage of the name. Following checks, the firm thinks accelerating mid-teens growth is doable in FY27-28 and likes the risk/reward in the stock from here, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix price target lowered to $60 from $75 at Goldman Sachs
- Nvidia initiated, DraftKings upgraded: Wall Street’s top analyst calls
- Nutanix downgraded to Equal Weight from Overweight at Barclays
- Nutanix downgraded to Equal Weight from Overweight at Morgan Stanley
- Nutanix price target lowered to $65 from $74 at RBC Capital